Ferdinando Di Cunto

Prof. Ferdinando Di Cunto

Department of Neuroscience 'Rita Levi Montalcini', Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, Italy
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Cell
Verified
Journal Article
Closed access
YTYvonne Tay
Yvonne Tay
LKLev Kats
Lev Kats
LSLeonardo Salmena
Leonardo Salmena
DWDror Weiss
Dror Weiss
STShen Mynn Tan
Shen Mynn Tan
PPPier Paolo Pandolfi
Pier Paolo Pandolfi

1 December 1996 in Genes & Development
Verified
Journal Article
Open access
PDF file
CMCaterina Missero
Caterina Missero
Ferdinando Di CuntoFerdinando Di Cunto
Ferdinando Di Cunto
Hiroaki KiyokawaHiroaki Kiyokawa
Hiroaki Kiyokawa
AKA Koff
A Koff
GDG P Dotto
G P Dotto
P21Cip1/WAF1 was the first cyclin-dependent kinase (CDK) inhibitor to be identified, as a mediator of p53 in DNA damage-induced growth arrest, cell senescence, and direct CDK regulation. p21 may also play an important role in differentiation-associated growth arrest, as its expression is augmented in many terminally differentiating cells. A general involvement of p21 in growth/differentiation control and tumor suppression has been questioned, as mice lacking p21 undergo a normal development, harbor no gross alterations in any of their organs, and exhibit no increase in spontaneous tumor development. However, a significant imbalance between growth and differentiation could be unmasked under conditions where normal homeostatic mechanisms are impaired. We report here that primary keratinocytes derived from p21 knockout mice, transformed with a ras oncogene, and injected subcutaneously into nude mice exhibit a very aggressive tumorigenic behavior, which is not observed with wild-type control keratinocytes nor with keratinocytes with a disruption of the closely related p27 gene. p21 knockout keratinocytes tested under well-defined in vitro conditions show a significantly increased proliferative potential, which is also observed but to a lesser extent with p27 knockout cells. More profound differences were found in the differentiation behavior of p21 versus p27 knockout keratinocytes, with p21 (but not p27) deficiency causing a drastic down-modulation of differentiation markers linked with the late stages of the keratinocyte terminal differentiation program. Thus, our results reveal a so far undetected role of p21 in tumor suppression, demonstrate that this function is specific as it cannot be attributed to the closely related p27 molecule, and point to an essential involvement of p21 in terminal differentiation control, which may account for its role in tumor suppression.

15 May 1998 in Science
Verified
Journal Article
Closed access
PDF file
Ferdinando Di CuntoFerdinando Di Cunto
Ferdinando Di Cunto
GTGabrielle Topley
Gabrielle Topley
ECEnzo Calautti
Enzo Calautti
JHJimmy Hsiao
Jimmy Hsiao
LOLydia Ong
Lydia Ong
GDG. Paolo Dotto
G. Paolo Dotto
The cyclin-dependent kinase inhibitor p21 Cip1/WAF1 has been implicated as an inducer of differentiation. However, although expression of p21 is increased in postmitotic cells immediately adjacent to the proliferative compartment, its expression is decreased in cells further along the differentiation program. Expression of the p21 protein was decreased in terminally differentiated primary keratinocytes of mice, and this occurred by a proteasome-dependent pathway. Forced expression of p21 in these cells inhibited the expression of markers of terminal differentiation at both the protein and messenger RNA levels. These inhibitory effects on differentiation were not observed with a carboxyl-terminal truncation mutant or with the unrelated cyclin-dependent kinase inhibitor p16 INK4a , although all these molecules exerted similar inhibition of cell growth. These findings reveal an inhibitory role of p21 in the late stages of differentiation that does not result from the effects of p21 on the cell cycle.

1 October 2000 in Neuron
Verified
Journal Article
Closed access
Ferdinando Di CuntoFerdinando Di Cunto
Ferdinando Di Cunto
SISara Imarisio
Sara Imarisio
EHEmilio Hirsch
Emilio Hirsch
VBVania Broccoli
Vania Broccoli
ABAlessandro Bulfone
Alessandro Bulfone
FAFiorella Altruda
Fiorella Altruda

30 January 2012 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
RPRosario M. Piro
Rosario M. Piro
Ferdinando Di CuntoFerdinando Di Cunto
Ferdinando Di Cunto

15 October 2011 in Molecular Biology of the Cell
Verified
Journal Article
Open access
MGMarta Gai
Marta Gai
PCPaola Camera
Paola Camera
ADAlessandro Dema
Alessandro Dema
FBFederico Bianchi
Federico Bianchi
GBGaia Berto
Gaia Berto
Ferdinando Di CuntoFerdinando Di Cunto
Ferdinando Di Cunto
The small GTPase RhoA plays a crucial role in the different stages of cytokinesis, including contractile ring formation, cleavage furrow ingression, and midbody abscission. Citron kinase (CIT-K), a protein required for cytokinesis and conserved from insects to mammals, is currently considered a cytokinesis-specific effector of active RhoA. In agreement with previous observations, we show here that, as in Drosophila cells, CIT-K is specifically required for abscission in mammalian cells. However, in contrast with the current view, we provide evidence that CIT-K is an upstream regulator rather than a downstream effector of RhoA during late cytokinesis. In addition, we show that CIT-K is capable of physically and functionally interacting with the actin-binding protein anillin. Active RhoA and anillin are displaced from the midbody in CIT-K-depleted cells, while only anillin, but not CIT-K, is affected if RhoA is inactivated in late cytokinesis. The overexpression of CIT-K and of anillin leads to abscission delay. However, the delay produced by CIT-K overexpression can be reversed by RhoA inactivation, while the delay produced by anillin overexpression is RhoA-independent. Altogether, these results indicate that CIT-K is a crucial abscission regulator that may promote midbody stability through active RhoA and anillin.